SCHEMBL20008068

SCHEMBL20008068

C=C/C(=C\C=C/C)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGM2 P21980 2/20 0.47
▸ TAS2R38 P59533 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ NAPRT Q6XQN6 1/20 0.38
▸ PHGDH O43175 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPC1 O15118 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15292671 1.00 TGM2 (0.47) TGM2TAS2R38HSD17B10NAPRTPHGDH
SCHEMBL13626039 0.94 MAPT (0.45) TGM2HSD17B10CYP1A2TSHRALDH1A1
SCHEMBL23050881 0.84 TGM2 (0.47) TGM2HSD17B10NAPRTTP53TSHR
SCHEMBL19993557 0.84 TGM2 (0.48) TGM2TAS2R38HSD17B10NAPRTPHGDH
SCHEMBL13514968 0.84 TAS2R38 (0.39) TGM2TAS2R38HSD17B10NAPRTPHGDH
SCHEMBL24450112 0.84 TAS2R38 (0.39) TGM2TAS2R38HSD17B10NAPRTPHGDH
SCHEMBL26080318 0.83 TGM2 (0.35) TGM2
SCHEMBL18392866 0.83 TGM2 (0.55) TGM2TAS2R38HSD17B10NAPRTPHGDH
SCHEMBL24158448 0.82 TAS2R38 (0.42) TGM2TAS2R38HSD17B10NAPRTPHGDH
SCHEMBL24158449 0.81 TGM2 (0.43) TGM2TAS2R38HSD17B10NAPRTPHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122078-A1 HETEROBIDENTATE IMIDAZO[1,5-A]PYRIDINE AND IMIDAZO[1,5-A]QUINOLINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-06-29 — — WO disclosed
US-20230143071-A1 FUSED POLYCYCLIC COMPOUND AND LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230036859-A1 PHOTORESIST, METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE AND METHOD OF EXTREME ULTRAVIOLET LITHOGRAPHY TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2023-02-02 — — US disclosed
EP-3516020-B1 ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS LANXESS CORP (US) 2022-05-25 — — EP disclosed
US-11180631-B2 Antioxidant composition SI GROUP USA (USAA), LLC (US) 2021-11-23 — — US disclosed
WO-2020195428-A1 RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN JSR株式会社 2020-10-01 — — WO disclosed
US-20200199483-A1 LUBRICATING OIL COMPOSITIONS WITH VISCOSITY CONTROL EXXONMOBIL RES & ENG CO (US) 2020-06-25 — — US disclosed
WO-2018057364-A1 LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS LANXESS SOLUTIONS US INC. (US) 2018-03-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143071-A1 FUSED POLYCYCLIC COMPOUND AND LIGHT EMITTING DEVICE INCLUDING THE SAME EMC2, EEF1A2, ECE2 TGM2 483/4885TAS2R38 3875/4885HSD17B10 1916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback